Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
jRCTs031210604Completed
Open-label trial of methoxyphenamine hydrochloride (2 arms). Primary endpoint: Urinary methoxyphenamine and o-desmethylmethoxyphenamine concentrations over time. Started Feb 2022; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on jRCTs031210604.